A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With Placebo

NCT01827982 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-54861911 1mg
DRUG: JNJ-54861911 3 mg
DRUG: JNJ-54861911 9 mg
DRUG: JNJ-54861911 27 mg
DRUG: JNJ-54861911 81 mg
DRUG: JNJ-54861911 160 mg
DRUG: JNJ-54861911 tbd
DRUG: JNJ-54861911 9 mg
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC